Solà Pérez Aleix, Pastorino David, Aparicio Carlos, Pegueroles Neyra Marta, Khan Rabia Sannam, Wright Simon, Ucer Cemal
Zygoma ZAGA Centers, Carrer Castellá 33, 08018 Barcelona, Spain.
Clínica Hepler Bone, Román Macaya 22, 08018 Barcelona, Spain.
Dent J (Basel). 2022 Aug 12;10(8):151. doi: 10.3390/dj10080151.
Zygomatic implants are a treatment solution for patients with severe maxillary atrophy. This treatment option allows delivering immediate fixed teeth within 24 h. Numerous peer-reviewed publications have reported different success rates, resulting in a disagreement on the topic. Therefore, the overall efficacy and predictability of this rehabilitation is still a matter of discussion. With this study, we aimed to identify the published literature on the use of zygomatic implants for the reconstruction of the severely atrophic maxilla and report the cumulative success rate (CSR) as a function of follow-up time. A systematic review of the literature on zygomatic implant for the treatment of severe maxillary atrophy was performed and 196 publications were included in the study. The cumulative success rate of zygomatic implants for the treatment of severe maxillary atrophy was 98.5% at less than 1 year, 97.5% between 1 and 3 years, 96.8% between 3 and 5 years and 96.1% after more than 5 years. The most commonly reported complications were soft tissue dehiscence, rhinosinusitis and prosthetic failures. The treatment of severe lack of bone in the upper maxilla with zygomatic implants is a safe procedure, reaching a cumulative success rate of 96.1% after more than 5 years.
颧骨种植体是治疗严重上颌骨萎缩患者的一种治疗方案。这种治疗选择能够在24小时内实现即刻固定义齿修复。众多经过同行评审的出版物报道了不同的成功率，导致在这个话题上存在分歧。因此，这种修复方式的总体疗效和可预测性仍是一个讨论的问题。通过本研究，我们旨在确定已发表的关于使用颧骨种植体修复严重萎缩上颌骨的文献，并报告作为随访时间函数的累积成功率（CSR）。对关于颧骨种植体治疗严重上颌骨萎缩的文献进行了系统回顾，196篇出版物纳入了本研究。颧骨种植体治疗严重上颌骨萎缩的累积成功率在1年以内为98.5%，1至3年为97.5%，3至5年为96.8%，5年以上为96.1%。最常报道的并发症是软组织裂开、鼻窦炎和修复体失败。使用颧骨种植体治疗上颌骨严重骨量不足是一种安全的手术，5年以上的累积成功率为96.1%。
